Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

PEG-3350 with electrolytes

Phase 3Small molecule

IIndiana University

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2027

ApprovedRecruiting

Constipation

NCT05821309

Clinical

Trials by Indication[1]

Colonoscopy1 trial

Study of Different Endoscopic Preparations Used in Pediatric Colonoscopy

Unknown status·FFundación Pública Andaluza para la gestión de la Investigación en Sevilla··NCT04153084·126 enrolled

Constipation1 trial

Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

Recruiting·IIndiana University·Approved·NCT05821309·65 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for PEG-3350 with electrolytes. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PEG-3350 with electrolytes compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PEG-3350 with electrolytes. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Indiana University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: IIndiana University

Related News